A New Interpretation of Antiestrogen Action

Annals of the New York Academy of Sciences

Volumn 761, Issue 1, 1995, Pages 109-120

  HEDDEN, ANNEMARIE ^a   MÜLLER, VOLKMAR ^a   JENSEN, ELWOOD V ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 11BETA [4 [5 (4,4,5,5,5 PENTAFLUOROPENTYLSULFONYL)PENTYLOXY]PHENYL]ESTRA 1,3,5(10) TRIENE 3,17 BETA DIOL; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CLOMIFENE; ESTROGEN RECEPTOR; ETHAMOXYTRIPHETOL; FULVESTRANT; NAFOXIDINE; NITROMIFENE; TAMOXIFEN; UNCLASSIFIED DRUG; ZM 164384;

ANIMAL CELL; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NONHUMAN; RAT;

ANIMALIA;

EID: 0029028824     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb31373.x     Document Type: Article

References (30)

1. A non‐steroidal estrogen antagonist 1‐(p‐2‐diethylaminoethoxyphenyl)‐1‐phenyl‐2‐p‐methoxyphenyl ethanol
2. The effect of oestrogen antagonists on the uptake of tritiated oestradiol by the uterus and vagina of the ovariectomized mouse
3. Biochemical pharmacology of antiestrogen action
4. Endocrine pharmacology of antiestrogens as antitumor agents
5. Gonadotrophs inhibiting and anti‐fecundity effects of chloramiphene
6. Antifertility activities of two diphenyl‐dihydronaphthalene derivatives
7. Action of an estrogen antagonist on reproductive mechanisms in the rat
8. A new derivative of triphenylethylene: effect on implantation and mode of action in rats
9. Novel antioestrogens without partial agonist activity
10. A potent specific pure antioestrogen with clinical potential
11. RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice
12. Estrogen receptor‐anti‐estrogen complex: atypical binding by uterine nuclei and effects on uterine growth
13. In vivo effect of anti‐estrogens on the localization and replenishment of estrogen receptor
14. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue
15. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover
16. Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor
17. Immunochemical studies of estrogen receptors
18. Identification of immunoassay able receptor lacking hormone binding ability in tamoxi‐fen‐treated rat uterus
19. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors
20. Modulation of estrogen receptor (ER) from tamoxifen in human breast cancer
21. Agonist‐antagonist activity of anti‐estrogens in the human breast cancer cell line MCF‐7: an hypothesis for the interaction with a site distinct from the estrogen binding site
22. Physical properties of estrogen receptor complexes in MCF‐7 human breast cancer cells
23. Differences between estrogen‐ and antiestrogen‐estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor
24. Mechanism of the estrogen receptor interaction with 4‐hydroxytamoxifen
25. Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen
26. Antagonism of estrogen action with a new benzothiophene derived antiestrogen
27. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF‐7 human breast cancer cells grown in the short‐term and long‐term absence of estrogens
28. Synthesis, conformational considerations, and estrogen receptor binding of diastereoisomers and enantiomers of l‐[4‐[2‐(dimethylamino)ethoxy]phenyl]‐1,2‐diphenylbutane (dihydroxytamoxifen)
29. Antiestrogenic properties of keoxifene, trans‐4‐hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR‐75‐1 human breast cancer cells